MetaCap

Scribe Therapeutics (SCTX) News

NASDAQ: SCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

12.07-1.15 (-8.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SCTX news summary

We found 5 recent headlines mentioning Scribe Therapeutics (SCTX): 2 in the past week and 3 in the past 30 days, most often from Nasdaq, GlobeNewswire. SCTX is making an outsized move today, down 8.70% at $12.07, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Scribe Therapeutics Reports Long-Lasting Cholesterol Reduction And Promising Lp(a) Data", was published by Nasdaq on Nov 18, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Scribe Therapeutics headlines

Stocks mentioned alongside SCTX

Compare SCTX